Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-course cyclophosphamide in colorectal cancer
ISRCTN12508004Phase 2Recruiting
- Sponsor
- Cardiff University
- Start
- Sep 2024
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of cyclophosphamide in colorectal cancer (CRC) (2 arms), sponsored by Cardiff University. Primary endpoint: Disease-free survival. Started Sep 2024; status: recruiting.
02
Drugs
cyclophosphamide
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ISRCTN12508004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12508004.